Atenolol's Inferior Ability to Reduce Central vs Peripheral Blood Pressure Can Be Explained by the Combination of Its Heart Rate-Dependent and Heart Rate-Independent Effects.

Conclusion: The findings of our trial with a mechanistic approach to the topic imply that the inferior ability of atenolol to reduce central vs peripheral BP can be explained by the combination of its heart rate-dependent and -independent effects. This trial is registered with NCT03245996. PMID: 32395337 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32395337?dopt=Abstract

Source: International Journal of Hypertension - May 14, 2020 Category: Cardiology Tags: Int J Hypertens Source Type: research